Inhibrx Biosciences, Inc. (INBX)

NASDAQ: INBX · Real-Time Price · USD

15.21

+0.61 (4.18%)

At close: Jun 18, 2025, 4:00 PM

15.16

-0.05 (-0.33%)

After-hours: Jun 18, 2025, 7:09 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Biologic Therapeutics	1.80M	Log In
Biologic Therapeutics Growth	-17.88%	Log In

Revenue by Geography

Fiscal year is January - December.